Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR trafficking

Nature Structural and Molecular Biology

Volumn 23, Issue 6, 2016, Pages 608-618

  Francavilla, Chiara ^a   Papetti, Moreno ^a   Rigbolt, Kristoffer T G ^b,c   Pedersen, Anna Kathrine ^a   Sigurdsson, Jon O ^a   Cazzamali, Giuseppe ^a   Karemore, Gopal ^a   Blagoev, Blagoy ^b   Olsen, Jesper V ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Present Address: Gubra   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; PROTEOME; RAB7 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR; MEMBRANE PROTEIN; RAB PROTEIN; RAB11FIP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; UBIQUITINATION; CELL MOTION; HELA CELL LINE; METABOLISM; PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; HELA CELLS; HUMANS; MEMBRANE PROTEINS; PHOSPHORYLATION; PROTEIN INTERACTION MAPS; PROTEIN TRANSPORT; PROTEOLYSIS; PROTEOMICS; RAB GTP-BINDING PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84965006770     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.3218     Document Type: Article

References (68)

1. Kholodenko, B. N. Untangling the signalling wires. Nat. Cell Biol. 9, 247-249 (2007).
2. Zheng, Y. et al. Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature 499, 166-171 (2013).
3. Purvis, J. E.&Lahav, G. Encoding and decoding cellular information through signaling dynamics. Cell 152, 945-956 (2013).
4. Sousa, L. P. et al. Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane. Proc. Natl. Acad. Sci. USA 109, 4419-4424 (2012).
5. Vieira, A. V., Lamaze, C.&Schmid, S. L. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274, 2086-2089 (1996).
6. Villaseñor, R., Nonaka, H., Del Conte-Zerial, P., Kalaidzidis, Y.&Zerial, M. Regulation of EGFR signal transduction by analogue-to-digital conversion in endosomes. eLife 4, e06156 (2015).
7. De Donatis, A. et al. Proliferation versus migration in platelet-derived growth factor signaling: The key role of endocytosis. J. Biol. Chem. 283, 19948-19956 (2008).
8. Francavilla, C. et al. The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J. Cell Biol. 187, 1101-1116 (2009).
9. Francavilla, C. et al. Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs. Mol. Cell 51, 707-722 (2013).
10. Parachoniak, C. A., Luo, Y., Abella, J. V., Keen, J. H.&Park, M. GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration. Dev. Cell 20, 751-763 (2011).
11. Sigismund, S. et al. Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol. Rev. 92, 273-366 (2012).
12. Mellman, I.&Yarden, Y. Endocytosis and cancer. Cold Spring Harb. Perspect. Biol. 5, a016949 (2013).
13. Kenakin, T. Functional selectivity and biased receptor signaling. J. Pharmacol. Exp. Ther. 336, 296-302 (2011).
14. Riese, D. J., II. Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery? Expert Opin. Drug Discov. 6, 185-193 (2011).
15. Ceresa, B. P.&Peterson, J. L. Cell and molecular biology of epidermal growth factor receptor. Int. Rev. Cell Mol. Biol. 313, 145-178 (2014).
16. Roepstorff, K. et al. Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic 10, 1115-1127 (2009).
17. Collinet, C. et al. Systems survey of endocytosis by multiparametric image analysis. Nature 464, 243-249 (2010).
18. Liberali, P., Snijder, B.&Pelkmans, L. A hierarchical map of regulatory genetic interactions in membrane trafficking. Cell 157, 1473-1487 (2014).
19. Altelaar, A. F., Munoz, J.&Heck, A. J. Next-generation proteomics: Towards an integrative view of proteome dynamics. Nat. Rev. Genet. 14, 35-48 (2013).
20. Hosp, F. et al. Quantitative interaction proteomics of neurodegenerative disease proteins. Cell Rep. 11, 1134-1146 (2015).
21. Larance, M.&Lamond, A. I. Multidimensional proteomics for cell biology. Nat. Rev. Mol. Cell Biol. 16, 269-280 (2015).
22. Olsen, J. V.&Mann, M. Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol. Cell. Proteomics 12, 3444-3452 (2013).
23. Nguyen, L. K., Kolch, W.&Kholodenko, B. N. When ubiquitination meets phosphorylation: A systems biology perspective of EGFR/MAPK signalling. Cell Commun. Signal. 11, 52 (2013).
24. Argenzio, E. et al. Proteomic snapshot of the EGF-induced ubiquitin network. Mol. Syst. Biol. 7, 462 (2011).
25. Li, J. et al. Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. Mol. Syst. Biol. 9, 705 (2013).
26. Olsen, J. V. et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648 (2006).
27. Omerovic, J., Hammond, D. E., Prior, I. A.&Clague, M. J. Global snapshot of the influence of endocytosis upon EGF receptor signaling output. J. Proteome Res. 11, 5157-5166 (2012).
28. Sigismund, S. et al. Clathrin-independent endocytosis of ubiquitinated cargos. Proc. Natl. Acad. Sci. USA 102, 2760-2765 (2005).
29. Sigismund, S. et al. Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev. Cell 15, 209-219 (2008).
30. Singh, B.&Coffey, R. J. From wavy hair to naked proteins: The role of transforming growth factor alpha in health and disease. Semin. Cell Dev. Biol. 28, 12-21 (2014).
31. Satpathy, S. et al. Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation. Mol. Syst. Biol. 11, 810 (2015).
32. Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011).
33. Sorkin, A.&Goh, L. K. Endocytosis and intracellular trafficking of ErbBs. Exp. Cell Res. 315, 683-696 (2009).
34. Caswell, P. T. et al. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J. Cell Biol. 183, 143-155 (2008).
35. Rigbolt, K. T. et al. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci. Signal. 4, rs3 (2011).
36. Alpi, A. F., Pace, P. E., Babu, M. M.&Patel, K. J. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol. Cell 32, 767-777 (2008).
37. Takayama, S. et al. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 16, 4887-4896 (1997).
38. Hunter, T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28, 730-738 (2007).
39. Ceresa, B. P.&Bahr, S. J. Rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome. J. Biol. Chem. 281, 1099-1106 (2006).
40. Zhang, M., Chen, L., Wang, S.&Wang, T. Rab7: roles in membrane trafficking and disease. Biosci. Rep. 29, 193-209 (2009).
41. Huang, F., Kirkpatrick, D., Jiang, X., Gygi, S.&Sorkin, A. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Mol. Cell 21, 737-748 (2006).
42. Sigismund, S. et al. Threshold-controlled ubiquitination of the EGFR directs receptor fate. EMBO J. 32, 2140-2157 (2013).
43. Olsen, J. V. et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 3, ra3 (2010).
44. Meijer, I. M., van Rotterdam, W., van Zoelen, E. J.&van Leeuwen, J. E. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH. Cell. Signal. 24, 1981-1988 (2012).
45. Mertins, P. et al. Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat. Methods 10, 634-637 (2013).
46. Sharma, K. et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 8, 1583-1594 (2014).
47. Woodman, P. ESCRT proteins, endosome organization and mitogenic receptor down-regulation. Biochem. Soc. Trans. 37, 146-150 (2009).
48. Komander, D.&Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203-229 (2012).
49. Schaeuble, K. et al. Ubiquitylation of the chemokine receptor CCR7 enables efficient receptor recycling and cell migration. J. Cell Sci. 125, 4463-4474 (2012).
50. Zhang, J. et al. RCP is a human breast cancer-promoting gene with Ras-activating function. J. Clin. Invest. 119, 2171-2183 (2009).
51. Behar, M., Barken, D., Werner, S. L.&Hoffmann, A. The dynamics of signaling as a pharmacological target. Cell 155, 448-461 (2013).
52. Moraga, I. et al. Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands. Cell 160, 1196-1208 (2015).
53. Wilson, K. J., Gilmore, J. L., Foley, J., Lemmon, M. A.&Riese, D. J. II. Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacol. Ther. 122, 1-8 (2009).
54. Topol, E. J. Individualized medicine from prewomb to tomb. Cell 157, 241-253 (2014).
55. Vizcaíno, J. A. et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069 (2013).
56. Shvets, E., Bitsikas, V., Howard, G., Hansen, C. G.&Nichols, B. J. Dynamic caveolae exclude bulk membrane proteins and are required for sorting of excess glycosphingolipids. Nat. Commun. 6, 6867 (2015).
57. Wagner, S. A. et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 10, M111 013284 (2011).
58. Wisniewski, J. R., Zougman, A., Nagaraj, N.&Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362 (2009).
59. Francavilla, C., Hekmat, O., Blagoev, B.&Olsen, J. V. SILAC-based temporal phosphoproteomics. Methods Mol. Biol. 1188, 125-148 (2014).
60. Lundby, A.&Olsen, J. V. GeLCMS for in-depth protein characterization and advanced analysis of proteomes. Methods Mol. Biol. 753, 143-155 (2011).
61. Rappsilber, J., Mann, M.&Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896-1906 (2007).
62. Kelstrup, C. D., Young, C., Lavallee, R., Nielsen, M. L.&Olsen, J. V. Optimized fast and sensitive acquisition methods for shotgun proteomics on a quadrupole orbitrap mass spectrometer. J. Proteome Res. 11, 3487-3497 (2012).
63. Cox, J.&Mann, M. MaxQuant enables high peptide identification rates, individualized p. p. b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
64. Cox, J. et al. Andromeda: A peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011).
65. Rigbolt, K. T., Vanselow, J. T.&Blagoev, B. GProX, a user-friendly platform for bioinformatics analysis and visualization of quantitative proteomics data. Mol. Cell. Proteomics 10, O110. 007450 (2011).
66. Franceschini, A. et al. STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815 (2013).
67. Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J.&Gevaert, K. Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 6, 786-787 (2009).
68. Huang, W., Sherman, B. T.&Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).